HCA Healthcare (NYSE:HCA) Given New $370.00 Price Target at KeyCorp

HCA Healthcare (NYSE:HCA) had its price target reduced by stock analysts at KeyCorp from $420.00 to $370.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. KeyCorp’s price objective indicates a potential upside of 20.54% from the stock’s current price.

A number of other equities analysts have also commented on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Oppenheimer upped their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Finally, Truist Financial lowered their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $385.27.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock traded up $10.04 during trading hours on Tuesday, hitting $306.96. 328,360 shares of the company’s stock traded hands, compared to its average volume of 978,835. The stock has a market capitalization of $77.75 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 1.21 and a beta of 1.64. The company has a fifty day simple moving average of $325.72 and a 200-day simple moving average of $354.69. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare has a 12-month low of $276.50 and a 12-month high of $417.14.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in HCA. Benjamin F. Edwards & Company Inc. purchased a new position in HCA Healthcare during the second quarter valued at $33,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare during the 3rd quarter valued at approximately $39,000. Canoe Financial LP bought a new position in HCA Healthcare in the 3rd quarter worth $41,000. Capital Performance Advisors LLP purchased a new position in HCA Healthcare during the third quarter valued at $41,000. Finally, Northwest Investment Counselors LLC purchased a new stake in HCA Healthcare during the 3rd quarter valued at $44,000. 62.73% of the stock is currently owned by institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.